Congressional Medicaid advisers said Friday (Sept. 15) that they'll probably steer clear of recommendations on Medicaid drug rebates. “I think I hear a consensus around that point that the appetite for thinking about a redo of the rebate program is not high, and I’m not sure that there’s a whole lot for us to do on some of the specific cost savers except to maybe acknowledge them if we come into a place where we have some recommendations,” said Penny...